| 0.4501 -0.044 (-8.89%) | 07-15 15:58 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.58 | 1-year : | 0.68 |
| Resists | First : | 0.5 | Second : | 0.58 |
| Pivot price | 0.44  |
|||
| Supports | First : | 0.43 | Second : | 0.38 |
| MAs | MA(5) : | 0.47 |
MA(20) : | 0.44 |
| MA(100) : | 0.45 |
MA(250) : | 0.69 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 82.3 |
D(3) : | 86.3 |
| RSI | RSI(14): 50.9 |
|||
| 52-week | High : | 1.58 | Low : | 0.28 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed below upper band by 41.5%. Bollinger Bands are 16.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.5 - 0.5 | 0.5 - 0.5 |
| Low: | 0.47 - 0.48 | 0.48 - 0.48 |
| Close: | 0.49 - 0.49 | 0.49 - 0.5 |
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Tue, 24 Jun 2025
Cosmos Health's Strategic Manufacturing Shift: A Shield Against Tariffs and a Path to Profitability - AInvest
Tue, 24 Jun 2025
Cosmos Health Makes Bold US Entry: Strategic Manufacturing Deal Eliminates Tariff Risks - Stock Titan
Tue, 06 May 2025
Cosmos Health Escapes Immediate Delisting Risk: Nasdaq Grants Critical 180-Day Extension - Stock Titan
Tue, 06 May 2025
Cosmos Health Inc. Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Nasdaq
Wed, 30 Apr 2025
Cosmos Health CEO boosts stake with $526,000 share purchase - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 29 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 31 (%) |
| Held by Institutions | 9.4 (%) |
| Shares Short | 493 (K) |
| Shares Short P.Month | 437 (K) |
| EPS | -1.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.94 |
| Profit Margin | -28.3 % |
| Operating Margin | -6.1 % |
| Return on Assets (ttm) | -14.9 % |
| Return on Equity (ttm) | -50.1 % |
| Qtrly Rev. Growth | -6 % |
| Gross Profit (p.s.) | 0.17 |
| Sales Per Share | 1.83 |
| EBITDA (p.s.) | -0.45 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.42 |
| PEG Ratio | 0 |
| Price to Book value | 0.47 |
| Price to Sales | 0.24 |
| Price to Cash Flow | -2.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|